Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Exciting Science School of Excellence for Grade 11 learners presented
2009-05-21

The Faculty of Natural and Agricultural Sciences at the University of the Free State (UFS) is presenting a Science School of Excellence for top achievers in Grade 11 from 6-9 July 2009. This will take place on the Main Campus in Bloemfontein.

Four exciting days are planned during which Grade 11 learners will participate in challenging extra-curricular exercises as well as laboratory and research activities. All classes will be presented in English and Afrikaans.

A maximum of 80 learners can be accommodated and selection will take place on the basis of first come, first accepted. An application fee of R50,00 per learner is payable.

The closing date for applications is 29 May 2009. The successful candidate will be notified telephonically. A further registration fee of R200,00 is payable by the successful learners. Learners are responsible for their own transport and accommodation. The registration fee includes all meals, lectures and activities.

In order to qualify for the UFS Science School, learners had to achieve an average of 80% [level 7] during the 2008 Grade 10 final examinations. They also had to obtain a minimum of 80% [level 7] in Mathematics and Physical or Life Sciences during the same examination. Learners who are interested in the Department of Computer Sciences and Informatics will also need Grade 10 CAT at level 7. A certified copy of the learner’s school report must accompany the application form.

“Our vision is to make the Faculty the preferred choice in central South-Africa for those who wish to pursue their studies in the natural and agricultural sciences,” said Prof. Neil Heideman, Vice-Dean of the faculty.

For application forms and enquiries, please contact the coordinator, Mr Johan Kruger, at 051 401 3199.

Media Release
Issued by: Lacea Loader
Assistant Director: Media liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
20 May 2009

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept